Skip to search formSkip to main contentSkip to account menu

Immunogenicity Study

Known as: IMMUNOGENICITY 
A study that assesses an agent's ability to provoke an immune response (humoral and/or cell-mediated) in the subject.
National Institutes of Health

Related topics

Related topics

2 relations
CDISC SDTM Trial Type TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Review
2017
Review
2017
The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design
The task of epitope discovery and vaccine design is increasingly reliant on bioinformatics analytic tools and access to… 
Highly Cited
2017
Highly Cited
2017
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells
ABSTRACT Extracellular vesicles (EVs) are under evaluation as therapeutics or as vehicles for drug delivery. Preclinical studies… 
Review
2016
Review
2016
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.
Highly Cited
2016
Highly Cited
2016
Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort.
BACKGROUND AND AIMS Biosimilar infliximab CT-P13 is approved for all indications of the originator product in Europe. Prospective… 
Review
2016
Review
2016
Biocompatibility evaluation of tissue-engineered decellularized scaffolds for biomedical application.
Highly Cited
2016
Highly Cited
2016
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.
BACKGROUND Three full doses of RTS,S/AS01 malaria vaccine provides partial protection against controlled human malaria parasite… 
Review
2015
Review
2015
Vaccine Adjuvants: from 1920 to 2015 and Beyond
The concept of stimulating the body’s immune response is the basis underlying vaccination. Vaccines act by initiating the innate… 
Highly Cited
2015
Highly Cited
2015
TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes
Significance The design of effective T-cell vaccines against pathogens and tumor antigens is challenged by the highly inefficient… 
Highly Cited
2014
Highly Cited
2014
Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine
HPV-023 (NCT00518336; ClinicalTrial.gov) is a long-term follow-up of an initial double-blind, randomized (1:1), placebo… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)